{'fraction_non_alphanumeric': 0.046753246753246755, 'fraction_numerical': 0.01038961038961039, 'mean_word_length': 5.4581005586592175, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Review of Diabetes Mellitus in Relation to Pancreatic Cancer

we look at the non-hereditary or sporadic forms of pancreatic cancer; several risk factors are playing major roles in the pathogenesis. The main factors are identified as age (>75%), smoking (cigarettes, cigars, pipes and chewing tobacco; 20%), obesity (>10%), chronic pancreatitis (long term inflammation of the pancreas;1%), diabetes, gallstones, metabolic syndrome, red meat, and exposure to high energy radiation (X-rays, gamma rays) [8]. Most of the patients (80-85%) are diagnosed with locally advanced or metastatic disease Abstract Pancreatic cancer (PC) and diabetes mellitus (DM) represent major research involvement worldwide. In the last few years, several clinical studies have confirmed that DM progression has a key role in the development of PC. In this mini-review, we analyze the current epidemiological data, in addition to the basic structural and physiological properties of pancreatic cancer tissue, and the relationship of cellular mechanisms between DM and subtypes of PC. We discuss current findings, as well as offer perspectives on proteomics and biomarker research.